MediWound Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MDWD | FBIO | MDXG | SLGL | CNXU | BLRX | |
|---|---|---|---|---|---|---|
| Market cap | 183.33M | 65.70M | 466.96M | 216.08M | 68.45M | 9.26M |
| P/E (TTM) | — | 0.7 | — | — | — | — |
| Forward P/E | -6.2 | -1.1 | 30.0 | -8.2 | -4.2 | -0.7 |
| Price/book | 5.1 | 0.4 | 2.2 | 4.5 | 10.4 | 0.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −26.23% | −21.77% | −59.17% | +95.14% | −81.79% | −45.11% |
| Today | +6.05% | +1.55% | −1.54% | +3.43% | −6.72% | −2.62% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All MDWD news ›MediWound Gains Attention from Wound Care Leaders as EscharEx Takes On Legacy SANTYL in $2.5B Market
WSW, NY, April 23rd, 2026, FinanceWire A 60-Year-Old Drug vs. a 5-Day Solution: Why Wound Care Giants Are Watching MediWound Recent News Highlights from MediWound (MDWD) Newly Published U.S. Expert Consensus Aligns with MediWound’s…
H.C. Wainwright Remains a Buy on Mediwound (MDWD)
In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Mediwound, with a price target of $36.00. According to TipRanks, Ramakanth is a 5-star analyst with an average return of 22.4% and a 46.41%…
Analysts Are Bullish on These Healthcare Stocks: Mediwound (MDWD), BridgeBio Pharma (BBIO)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Mediwound (MDWD), BridgeBio Pharma (BBIO) and Tandem Diabetes Care (TNDM) with bullish sentiments. In a report released today, Josh Jennings…
MediWound Ltd. (NASDAQ:MDWD) Stock Has Consensus Target Price of $33.00 According to Brokerages
Posted by Sarita Garza on Oct 14th, 2026 Read Our Latest Analysis on MediWound In other news, COO Shmuel Hess sold 3,958 shares of the stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $12.92, for a…
Taysha Gene Therapies (NASDAQ:TSHA) versus MediWound (NASDAQ:MDWD) Head to Head Analysis
Posted by Defense World Staff on Oct 9th, 2026 Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and MediWound (NASDAQ:MDWD – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- theglobeandmail.com3
- defenseworld.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.